FORM 4
 
Check this box if no longer
subject to Section 16. Form 4 or
Form 5 obligations may continue.
See Instruction 1(b).
(Print or type responses) U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
 
 
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 OMB APPROVAL
 
OMB Number: 3235-0287
Expires: December 31, 2001
Estimated average burden
hours per response. . . . .0.5

1. Name and Address of Reporting Person*

Radlick	Phil
(Last)	(First)	(Middle)

c/o Lipid Sciences, Inc.
7068 Koll Center Parkway, Suite 401

(Street)

Pleasanton,	California	94566
(City)	(State)	(Zip)

2.	Issuer Name and Ticker or Trading Symbol
	Lipid Sciences, Inc. (LIPD)

3. I.R.S. or Social Security Number of Reporting Person (Voluntary)
 
 
 

4.	Statement for Month/Year
	May 2002

5. If Amendment, Date of Original (Month/Year)

6. Relationship of Reporting Person to Issuer (Check all applicable)

	Director		10% Owner
	Officer (give title below)		Other (specify below)

President and Chief Executive Officer

7.	Individual or Joint/Group Filing (Check Applicable Line)
	Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I — Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security	2. Trans-	3. Trans-		4. Securities Acquired (A)			5. Amount of	6. Ownership	7. Nature of
(Instr. 3)	action	action		or Disposed of (D)			Securities	Form:	Indirect
	Date	Code		(Instr. 3, 4 and 5)			Beneficially	Direct	Bene-
		(Instr. 8)					Owned at	(D) or	ficial
	(Month/						End of	Indirect	Owner-
	Day/				(A) or		Month	(I)	ship
	Year)	Code	V	Amount	(D)	Price	(Instr. 3 and 4)	(Instr. 4)	(Instr. 4)
Common Stock	5/02/2002	P		200	A	$5.16	200	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).	(Over)

FORM 4 (continued) Table II — Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security

2.Conver-

3.Trans-

4. Trans-

5. Number of Deriv-

6. Date Exerc-

7. Title and

8.Price

9. Number

10. Owner-

11. Nature

(Instr. 3)

sion or

action

action

ative Securities Ac-

isable and

Amount of

of

of deriv-

ship

of

Exercise

Date

Code

quired (A) or Dis-

Expiration

Underlying

Deriv-

ative

Form of

Indirect

Price of

(Instr. 8)

posed of (D)

Date

Securities

ative

Secur-

Deriv-

Benefi-

Deriv-

(Month/

(Instr. 3, 4 and 5)

(Month/Day/

(Instr. 3 and 4)

Secur-

ities

ative

cial

ative

Day/

Year)

ity

Bene-

Security

Owner-

Security

Year)

(Instr. 5)

ficially

Direct

ship

Owned

(D) or

(Instr. 4)

at End

Indirect

of

(I)

Month

(Instr. 4)

(Instr. 4)

Date

Expira-

Amount

Exer-

tion

or

Code

V

(A)

(D)

cisable

Date

Title

Number

of Shares

Explanation of Responses:

**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18. U.S.C. 1001 and 15 U.S.C. 78ff(a).	/s/ Phil Radlick	5/10/02
		** Signature of Reporting Person	Date

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond
unless the form displays a currently valid OMB number.

Page 2